Kumaree Pachanee Researcher of Foundation for Health Technology Assessment and Policy Evaluation (2020–Present)Kumaree holds a master’s degree in political economy and governance, (Political Science), from Burapha University. Since 2010, she has played a central role in research project management and policy research related to the development of h

Dr. Wanrudee Isaranuwatchai is a Secretary General and Senior Researcher of the Health Intervention and Technology Assessment Program Foundation (HITAP), Thailand. She is also an Affiliated Scientist at St. Michael’s Hospital, and an Associate Professor at the Institute of Health Policy, Management and Evaluation, University of Toronto, in Canada.H

With governments around the world committing to Universal Health Coverage, it is increasingly important to ensure that they have the right tools to the address the challenges they will face. Evidence-informed decision making to ensure efficient allocation of resources in the system is vital. The Int

Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health through the International Decision Support Initiative (iDSI) has been working in Vietnam since 2014. iDSI has supported Ministry of Health (MOH) Vietnam in realising Universal Health Coverage (UHC) through a dif

This visit is a part of the project to support the development of health technology assessment (HTA) in Vietnam, under the auspices of the International Decision Support Initiative (iDSI). This visit represents an ongoing collaboration between the Health Intervention and Technology Assessment Progra

This mission report summarises the activities and discussions during the second meeting of the Unit for Health Evidence and Policy (UHEP), held on September 1st, 2022. This meeting aimed to promote the understanding of Health Technology Assessment (HTA) topic prioritisation in Lao PDR and sharing Th

Estimating the willingness to pay for a quality-adjusted life year in Thailand: does the context of health gain matter? Thavorncharoensap M1, Teerawattananon Y, Natanant S, Kulpeng W, Yothasamut J, Werayingyong P 1Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Thailand ; Heal

Cost-utility analysis of 10- and 13-valent pneumococcal conjugate vaccines: Protection at what price in the Thai context? Wantanee Kulpenga, b, , , , Pattara Leelahavaronga, , Waranya Rattanavipaponga, , Vorasith Sornsrivichaib, , Henry C. Baggettc, , Aronrag Meeyaia, d, , , Warunee Punpaniche, ,

Yot Teerawattananon,1 Sripen Tantivess,1 Pitsaphun Werayingyong,1 Pritaporn Kingkaew,1 Nilar Tin,2 San San Aye,3 Phone Myint3 Abstract Introduction: In 2010, with financial support from the Global Alliance for Vaccine and Immunization’s Health System Strengthening programme, the Government of

Katharina Kieslich1,*, Jesse B. Bump2 , Ole Frithjof Norheim3 , Sripen Tantivess4 and Peter Littlejohns1 1 Faculty of Life Sciences & Medicine, Division of Health and Social Care Research, King’s College London, London, UK 2 Department of Global Health and Population, Harvard T. H. Chan School o